Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis
Zebrafish as a model to investigate CNS myelination.
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
Trimesta (Oral Estriol)
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
Treatment Burden and Chronic Illness: Who is at Most Risk?
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Pages
« first
‹ previous
…
40
41
42
43
44
45
46
47
48
…
next ›
last »